Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Metabolic brain imaging in genetic Parkinson's disease: from genes to network trajectories.

Parkinsonism & related disorders·2026
Same author

Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial.

Nature medicine·2026
Same author

Cortical gray-white matter contrast alterations precede amyloid-β positivity and macrostructural changes in older adults without dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Investigating AD and non-AD [<sup>18</sup>F]flortaucipir distribution patterns in a memory clinic cohort.

European journal of nuclear medicine and molecular imaging·2026
Same author

Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in females.

European journal of nuclear medicine and molecular imaging·2026
Same author

[Chronic coronary syndrome : advanced cardiac imaging].

Revue medicale suisse·2026

相关实验视频

Updated: Jun 17, 2026

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

19.7K

-PET的视觉分类检测到4个亚型,具有不同的长期结果.

Cecilia Boccalini1, Gregory Mathoux2, Ines Hristovska3

  • 1Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocenter and Faculty of Medicine, University of Geneva, Switzerland.

Neurology
|September 12, 2025
PubMed
概括

视觉tau-PET分类可靠地确定了四种阿尔茨海默病亚型,具有独特的临床特征和结果. 这种方法有助于检测高风险的变体,以进行个性化诊断和治疗.

更多相关视频

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
09:12

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

6.7K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

819

相关实验视频

Last Updated: Jun 17, 2026

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

19.7K
Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
09:12

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

6.7K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

819

科学领域:

  • 神经成像是一种神经成像.
  • 阿尔茨海默氏症疾病研究研究
  • 生物标志物发现发现

背景情况:

  • 阿尔茨海默病 (AD) 呈现出可变的积模式.
  • 一种数据驱动的方法确定了四种不同的tau时空轨迹 (SuStaIn).
  • 临床翻译需要一种视觉方法来识别这些tau亚型.

研究的目的:

  • 建立一种标准化的视觉拓方法,使用tau-PET识别tau图案.
  • 在临床环境中验证视觉亚型分类.
  • 评估视觉tau模式识别的临床实用性.

主要方法:

  • 来自记忆诊所的245名tau-PET扫描患者的前性研究.
  • 用视觉评分和SuStain算法将tau-PET扫描分为四个亚型 (S1-S4) 的分类.
  • 统计分析评价者之间的一致性 (科恩的 κ) 和亚型之间的临床/生物标志物特征的差异.

主要成果:

  • 评级者之间对视觉tau亚型解释的实质性协议 (κ > 0.65).
  • 视觉和自动化tau亚型分类之间的公平协议 (κ = 0.39).
  • 视觉分类确定了具有不同全球tau负载,临床特征和认知衰退率的亚型.

结论:

  • 视觉tau-PET分类可靠地识别出阿尔茨海默病中的四种不同的tau模式.
  • 这些模式与临床特征和长期结果相关,表明临床有用性.
  • 这种方法支持个性化诊断和预后更高风险的AD变体.